Average Insider

Where insiders trade, we follow

$TKNO
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Stephen Gunstream
CEO
173
Employees
$2.79
Current Price
$216.26M
Market Cap
52W Low$1.91
Current$2.7915.8% above low, 84.2% below high
52W High$7.48

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys22$143,417.2066,000All Buys
Sells00--
2 monthsBuys22$143,417.2066,000All Buys
Sells00--
3 monthsBuys22$143,417.2066,000All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Mar 6, 2026
Lowell Matthew
Chief Financial Officer
Purchase40,000$2.19$87,616.00View Details
Mar 6, 2026
Gunstream Stephen
Director
Purchase26,000$2.15$55,801.20View Details
1 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Mar 3, 2026
EPS
Estimated-$0.09
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Feb 26, 2026
EPS
Estimated-$0.09
ActualN/A
Revenue
Estimated$9.62M
ActualN/A
Version: v26.3.29